Fuss Brands Corp.

Fuss Brands Corp.

FBDS
Fuss Brands Corp.US flagOther OTC
0.10
USD
- -
- -
2.17MMarket Cap
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
- -
20.81
25.54
31.28
38.53
50.77
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
7.12
7.62
10.7
12.48
18.1
-76.73
- -
- -
-0.23
-0.01
-0.03
-0.14
-0.01
Free Cash Flow per Basic Share
- -
6.55
-0.99
-2.27
13.36
-9.44
- -
- -
- -
-0.05
-0.01
-0.01
-0.02
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
8.92
15.76
28.1
39.7
55.44
-21.28
-21.28
-8.17
-8.42
-1.59
-0.77
-0.81
-0.75
Tangible Book Value per Share
- -
15.87
25.22
36.35
47.34
57.61
-7.14
-7.14
- -
-0.02
-0.01
-0.03
-0.04
-0.04
Basic Weighted Avg Shares
- -
1
1
1
1
1
1
1
1
1
8
16
19
21
Sales/Revenue/Turnover
- -
28
34
43
55
73
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
29.51
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
10
10
15
18
26
-110
- -
- -
- -
- -
-1
-3
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
12.57
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
34.22
29.85
34.2
32.38
35.65
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
8
19
31
32
47
41
-10
-10
- -
- -
- -
- -
-1
-1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
11
21
34
50
70
100
-10
-10
- -
- -
- -
- -
-1
-1
Return on Invested Capital (%)
- -
- -
36.25
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
122.97
61.82
49.26
37.28
38.04
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
122.97
61.82
49.26
37.28
38.04
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Jan'25
Apr'25
Jul'25
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
21
21
Market Capitalization
- -
- -
1

Working Capital

FRC

in mil. unless spec.
Jan'25
Apr'25
Jul'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
53.2%
Free Cash Flow
- -
- -
325%
Net Income, GAAP
- -
- -
445.41%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
-0.01
-0.01
- -
-0.03
2024
- -
-0.14
- -
- -
-0.14
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Cheskel Meisels
Full Time Employees
1
Sector
Financial Services
Industry
Shell Companies
Address
80 Broad Street New York City NY United States of America 10004
IPO Date
Mar 27, 2000
Business
Fuss Brands Corp. has evolved from its prior designation as a shell entity, now engaging in active business operations within the United States. The company is primarily focused on the development and global distribution of innovative travel solutions. This includes patented expandable luggage, designed to transition between carry-on and full-size capacities, along with specialized laptop bags tailored for modern travelers. To support its product offerings, Fuss Brands holds exclusive worldwide licensing rights for specific technologies, such as the Fugu Luggage brand. Furthermore, the organization has established manufacturing and sales agreements to facilitate the production and market reach of its offerings. The firm, which commenced operations in 1988, adopted the Fuss Brands Corp. name in July 2022, having previously operated as China Botanic Pharmaceutical Inc., and maintains its headquarters in New York, New York.